Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON37582Phase 4Recruiting
Phase 4, open-label trial of metformin and dipyridamole (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Metformin plasma AUC and Metformin Cmax. Started Apr 2012; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON37582.